PolyNovo (ASX:PNV) reported Friday that it swung to earnings per share in the fiscal year ended June 30 of AU$0.75, compared with the prior-year period's loss of AU$0.72 per share.
Revenue from ordinary activities was AU$104.7 million, up 57% from AU$66.5 million in the same period last year.
The medical devices business did not pay, recommend or declare a dividend in the fiscal year ended June 30.
Shares rose marginally in Friday trade.
Price (AUD): $2.58, Change: $-0.015, Percent Change: -0.58%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments